Exchange: NASDAQ·Updated 12:00 AM EST
News
all
press releases
Taysha Gene Therapies Stock Soars After FDA Grants Breakthrough Therapy Designation To Gene Therapy
Taysha also announced that it has finalized alignment with the FDA on the protocol for the trial intended to support its application for approval of TSHA-102.
Stocktwits

Advertisement|Remove ads.